Shahamat Syed Tauhid, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 39 | 2024 | 3222 | 2.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 15 | 2024 | 556 | 1.520 |
Why?
|
Atrophy | 26 | 2024 | 1633 | 1.290 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 6 | 2021 | 254 | 0.690 |
Why?
|
Magnetic Resonance Imaging | 43 | 2024 | 36426 | 0.650 |
Why?
|
Brain | 31 | 2024 | 27121 | 0.590 |
Why?
|
Spinal Cord | 10 | 2019 | 1819 | 0.520 |
Why?
|
Disability Evaluation | 13 | 2024 | 1836 | 0.410 |
Why?
|
Employment | 1 | 2015 | 1118 | 0.320 |
Why?
|
Severity of Illness Index | 6 | 2017 | 15843 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2024 | 9001 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2019 | 3359 | 0.200 |
Why?
|
Toluidines | 1 | 2020 | 21 | 0.180 |
Why?
|
Crotonates | 1 | 2020 | 21 | 0.180 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4176 | 0.170 |
Why?
|
Adult | 44 | 2024 | 221210 | 0.160 |
Why?
|
Middle Aged | 41 | 2024 | 220921 | 0.160 |
Why?
|
Substantia Nigra | 1 | 2020 | 350 | 0.160 |
Why?
|
Meninges | 1 | 2019 | 198 | 0.150 |
Why?
|
Fluorine Radioisotopes | 1 | 2019 | 418 | 0.130 |
Why?
|
Male | 45 | 2024 | 360846 | 0.130 |
Why?
|
Demyelinating Diseases | 2 | 2015 | 352 | 0.120 |
Why?
|
Female | 44 | 2024 | 392705 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2020 | 6484 | 0.120 |
Why?
|
Organ Size | 5 | 2017 | 2254 | 0.110 |
Why?
|
Sample Size | 1 | 2017 | 841 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1552 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4062 | 0.100 |
Why?
|
Sensitivity and Specificity | 9 | 2018 | 14665 | 0.100 |
Why?
|
MicroRNAs | 2 | 2019 | 3816 | 0.100 |
Why?
|
Cerebral Cortex | 3 | 2017 | 5779 | 0.100 |
Why?
|
Microglia | 1 | 2020 | 1362 | 0.100 |
Why?
|
Humans | 50 | 2024 | 761596 | 0.090 |
Why?
|
Disease Progression | 6 | 2019 | 13510 | 0.090 |
Why?
|
Adjuvants, Immunologic | 1 | 2016 | 1036 | 0.090 |
Why?
|
Image Enhancement | 4 | 2014 | 2884 | 0.090 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 957 | 0.080 |
Why?
|
Young Adult | 13 | 2021 | 59260 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2015 | 980 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2650 | 0.080 |
Why?
|
Quality of Life | 3 | 2021 | 13367 | 0.080 |
Why?
|
Acetanilides | 2 | 2020 | 169 | 0.080 |
Why?
|
Pilot Projects | 5 | 2022 | 8633 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2016 | 1590 | 0.070 |
Why?
|
Artifacts | 1 | 2014 | 1911 | 0.060 |
Why?
|
Pattern Recognition, Automated | 3 | 2018 | 997 | 0.060 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20100 | 0.060 |
Why?
|
Thalamus | 3 | 2018 | 1047 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2011 | 952 | 0.060 |
Why?
|
Glia Maturation Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Algorithms | 4 | 2018 | 14033 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5821 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9758 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 80647 | 0.040 |
Why?
|
Hydroxybutyrates | 1 | 2020 | 79 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2850 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 641 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3980 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2023 | 982 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16592 | 0.030 |
Why?
|
Putamen | 1 | 2017 | 292 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14608 | 0.030 |
Why?
|
Globus Pallidus | 1 | 2017 | 250 | 0.030 |
Why?
|
Spinal Cord Diseases | 1 | 2019 | 292 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 823 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2016 | 554 | 0.030 |
Why?
|
Nitriles | 1 | 2020 | 971 | 0.030 |
Why?
|
Automation | 1 | 2017 | 586 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 492 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12794 | 0.030 |
Why?
|
Cohort Studies | 4 | 2019 | 41495 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2606 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2057 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3156 | 0.020 |
Why?
|
Gadolinium | 1 | 2015 | 960 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26129 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2014 | 7054 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39106 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2526 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4853 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2009 | 390 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2014 | 2358 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5872 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2009 | 554 | 0.020 |
Why?
|
Prospective Studies | 3 | 2018 | 54423 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3028 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2017 | 64685 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 2009 | 748 | 0.020 |
Why?
|
Reference Values | 1 | 2011 | 4920 | 0.010 |
Why?
|
Functional Laterality | 1 | 2009 | 2257 | 0.010 |
Why?
|
Aged | 3 | 2020 | 169310 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10774 | 0.010 |
Why?
|
Software | 1 | 2015 | 4434 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6228 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
Cognition | 1 | 2014 | 6992 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 88326 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39969 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81539 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22176 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168475 | 0.000 |
Why?
|